Community Schedule

You are currently viewing October 2025

1 results showing for: 'nirmatrelvir with ritonavir'

Nirmatrelvir with ritonavir

- PCT
- Subsidy by endorsement

Tab 150 mg with ritonavir 100 mg
- Brand Fully subsidised brand. Paxlovid
- Pharmacode2711613
- Subsidy $1274.00
- Measure / Qty per 30 OP

Tab 150 mg with ritonavir 100 mg, [Xpharm]
- Brand Fully subsidised brand. Paxlovid (Pharmac)
- Pharmacode2635143
- Subsidy $0.00
- Measure / Qty per 30
(Paxlovid (Pharmac) Tab 150 mg with ritonavir 100 mg, to be delisted 01 December 2025)

Subsidised for patients meeting access criteria for oral COVID-19 antiviral treatments (as on Pharmac’s website) and where the prescription is endorsed accordingly. Pharmacists may annotate the prescription as endorsed when supplying by Direct Provision under the provisions in Part I of Section A of the Pharmaceutical Schedule.

For eye preparations refer to Eye Preparations, Anti-Infective Preparations, page 277

Rectangle page icon symoblising a PDF. PDF
A tick icon. Fully subsidised
An oval with the number 29 in it. Unapproved medicine under Section 29
An asterisk symbol. 3 or 6 months should be dispensed at once
Two duplicate pages icon. Click to copy
A triangle symbol. Three months supply may be dispensed at one time if endorsed "certified exemption" by the prescriber or pharmacist.
OP Original pack
Sole Subsidised Supply